24/7 BIOPHARMA - issue 1 / October 2024

WELCOME

Unveiling a new era in pharmaceutical media

In a world where information is not just power but a necessity, the launch of our new media platform, 24/7 Biopharma, marks a transformative step in how the biopharma industry communicates, collaborates, and innovates. As we prepare to attend CPHI Milan 2024 as an official media partner, we are excited to embark on this journey that promises to redefine industry engagement and elevate the discourse surrounding pharmaceutical advancements. Our new media platform is designed to bridge the gap between biopharma professionals and the wealth of knowledge, insights, and innovations emerging daily. With a focus on delivering high-quality content, expert analysis, and real-time updates, we aim to foster a dynamic community where industry stakeholders can connect, share, and grow together. This platform is not just a publication; it is a hub for collaboration, inspiration, and action in an ever-evolving landscape. Attending CPHI Milan 2024 provides a unique opportunity to showcase this platform to a global audience of industry leaders, innovators, and decision makers. As one of the largest gatherings in the pharmaceutical sector, CPHI Milan is the ideal venue for us to connect with our peers, share our vision, and explore the latest trends and technologies shaping the future of healthcare. Our presence as a media partner underscores our commitment to amplifying the voices of those driving change in the industry. Sustainability and innovation will also take center stage during our time in Milan. Our new media platform will actively engage with thought leaders and innovators who are pioneering sustainable practices and cutting

edge technologies in pharma. By sharing these stories, we hope to inspire a movement towards a more responsible and forward-thinking industry, where collaboration is key to tackling global health challenges. Moreover, CPHI Milan serves as an excellent opportunity for us to gather insights directly from the ground. We will be conducting interviews and capturing the pulse of the event to provide our audience with comprehensive coverage that reflects the diverse and vibrant nature of the pharmaceutical community. Our commitment to delivering timely and relevant content will ensure that our audience remains informed and engaged long after the event concludes. In conclusion, the launch of our new media platform coincides with an exciting chapter in the biopharma industry, and attending CPHI Milan 2024 as a media partner represents our dedication to being at the forefront of this evolution. We invite all industry professionals to join us on this journey as we strive to create a platform that not only informs but inspires action and collaboration. Together, let’s shape the future of biopharma media and drive positive change in healthcare.

ELLIE BRUNI Publishing Director TWENTYFOURSEVENBIOPHARMA

Publishing Director: Ellie Bruni | +44 (0) 7872 516194 ellie.bruni@247biopharma.com Advertising: info@247biopharma.com Editorial contact: Please send your news and suggestions for feature articles to the editorial team at editor@247biopharma.com

Av. Diagonal, 409, 1St Floor, 08008, Barcelona, Spain.

any false claims made by advertisers, or in articles contributed by external authors. Copyright: The contents of this publication are copyright © BIBO Publishing SL 2024. No part of this publication can be reproduced or transmitted in any form without the express permission of the publisher.

Disclaimer: The disclaimer has an error: BIBO Publishing SL will not be held responsible or liable for errors or omissions supplied or contained in this publication, although due care and attention are taken to ensure all content is accurate at the time of going to press. BIBO Publishing SL also will not be held responsible for

TWENTYFOURSEVENBIOPHARMA is published by BIBO Publishing SL,

ISSN 2516-4481